Factors Influencing Men Undertaking Active Surveillance for the Management of Low-Risk Prostate Cancer

被引:75
|
作者
Davison, B. Joyce [1 ,2 ]
Oliffe, John L. [3 ]
Pickles, Tom [4 ]
Mroz, Lawrence
机构
[1] Univ British Columbia, Dept Urol, Vancouver, BC V5Z 1M9, Canada
[2] Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC, Canada
[3] Univ British Columbia, Sch Nursing, Vancouver, BC V5Z 1M9, Canada
[4] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
基金
加拿大健康研究院;
关键词
QUALITY-OF-LIFE; SELECTIVE DELAYED INTERVENTION; RADICAL PROSTATECTOMY; EXPECTANT MANAGEMENT; CAPSURE; INFORMATION; CARCINOMA; PARTNERS; BRACHYTHERAPY; PREFERENCES;
D O I
10.1188/09.ONF.89-96
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose/Objectives: To identify and describe decision-making influences on men who decide to manage their low-risk prostate cancer with active surveillance. Research Approach: Qualitative, semistructured interview. Setting: The Prostate Centre at Vancouver General Hospital in Canada. Participants: 25 patients diagnosed with low-risk prostate cancer and on active Surveillance. Methodologic Approach: An interpretative, descriptive, qualitative design. Main Research Variables: Factors that influenced men's decisions to take up active surveillance. Findings: The specialists' description of the prostate cancer was the most influential factor on men choosing active surveillance. Patients did not consider their prostate cancer to be life threatening and, in general, were relieved that no treatment was required. Avoiding treatment-related suffering and physical dysfunction and side effects such as impotence and incontinence was cited as the major reason to delay treatment. Few men actively sought treatment or health-promotion information following their treatment decision. Female partners played a supportive role in the decision. The need for active treatment if the cancer progressed was acknowledged. Patients were hopeful that new treatments would be available when and if they needed them. Being older and having comorbidities did not preclude the desire for future active treatment. Patients carried on with their lives as usual and did not report having any major distress related to being on active surveillance. Conclusions: The study findings indicate that men are strongly influenced by the treating specialist in taking up active surveillance and planning future active treatments. As such, most men relied on their specialists' recommendation and did not perceive the need for any adjunct therapy or support until the cancer required active treatment. Interpretation: Oncology nurses should work collaboratively with specialists to ensure that men receive the information they need to make informed treatment decisions.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 50 条
  • [41] Variation in the use of active surveillance for low-risk prostate cancer
    Loeppenberg, Bjoern
    Friedlander, David F.
    Krasnova, Anna
    Tam, Andrew
    Leow, Jeffrey J.
    Nguyen, Paul L.
    Barry, Hawa
    Lipsitz, Stuart R.
    Menon, Mani
    Abdollah, Firas
    Sammon, Jesse D.
    Sun, Maxine
    Choueiri, Toni K.
    Kibel, Adam S.
    Quoc-Dien Trinh
    CANCER, 2018, 124 (01) : 55 - 64
  • [42] Active Surveillance for Low-Risk Prostate Cancer in Black Patients
    Butler, Santino
    Muralidhar, Vinayak
    Chavez, Janice
    Fullerton, Zoe
    Mahal, Aman
    Nezolosky, Michelle
    Vastola, Marie
    Zhao, Shuang G.
    D'Amico, Anthony V.
    Dess, Robert T.
    Feng, Felix Y.
    King, Martin T.
    Mouw, Kent W.
    Spratt, Daniel E.
    Quoc-Dien Trinh
    Nguyen, Paul L.
    Rebbeck, Timothy R.
    Mahal, Brandon A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (21): : 2070 - 2072
  • [43] THE ERA OF ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER IS HERE
    Sountoulides, Petros
    Obek, Can
    ARCHIVOS ESPANOLES DE UROLOGIA, 2016, 69 (02): : 49 - 51
  • [44] Active Surveillance for Low-risk Prostate Cancer: Will it Become Obsolete?
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2019, 75 (05) : 750 - 751
  • [45] Super active surveillance for low-risk prostate cancer | Opinion: No
    Ghodoussipour, Saum
    Lebastchi, Amir
    Pinto, Peter
    Berger, Andre
    INTERNATIONAL BRAZ J UROL, 2019, 45 (02): : 215 - 219
  • [46] Active surveillance beats surgery in low-risk prostate cancer
    Brower, Vicki
    LANCET ONCOLOGY, 2012, 13 (11): : E468 - E468
  • [47] Active Surveillance for Low-risk Prostate Cancer: Developments to Date
    Bangma, Chris H.
    Valdagni, Riccardo
    Carroll, Peter R.
    van Poppel, Hein
    Klotz, Laurence
    Hugosson, Jonas
    EUROPEAN UROLOGY, 2015, 67 (04) : 646 - 648
  • [48] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Katsuyoshi Hashine
    Hiroyuki Iio
    Yoshiteru Ueno
    Shohei Tsukimori
    Iku Ninomiya
    International Journal of Clinical Oncology, 2014, 19 : 531 - 535
  • [49] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Hashine, Katsuyoshi
    Iio, Hiroyuki
    Ueno, Yoshiteru
    Tsukimori, Shohei
    Ninomiya, Iku
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (03) : 531 - 535
  • [50] Contemporary Use of Initial Active Surveillance Among Men in Michigan with Low-risk Prostate Cancer
    Womble, Paul R.
    Montie, James E.
    Ye, Zaojun
    Linsell, Susan M.
    Lane, Brian R.
    Miller, David C.
    EUROPEAN UROLOGY, 2015, 67 (01) : 44 - 50